Subcutaneous immunotherapy with a depigmented polymerized birch pollen extract - A new therapeutic option for patients with atopic dermatitis

International Archives of Allergy and Immunology

Volumn 155, Issue 3, 2011, Pages 252-256

  Novak, Natalija ^a   Thaci, Diamant ^b   Hoffmann, Matthias ^c   Fölster Holst, Regina ^d   Biedermann, Thilo ^e   Homey, Bernhard ^f   Schaekel, Knut ^g   Stefan, Josef A ^c   Werfel, Thomas ^h   Bieber, Thomas ^a   Sager, Angelika ⁱ   Zuberbier, Torsten ^j  

^a UNIVERSITY OF BONN   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c Dermatology Practice   (Germany)

^d UNIVERSITY OF KIEL   (Germany)

^e UNIVERSITY OF TÜBINGEN   (Germany)

^f HEINRICH HEINE UNIVERSITY   (Germany)

^g DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^h HANNOVER MEDICAL SCHOOL   (Germany)

ⁱ LETI Pharma GmbH   (Germany)

^j CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

more..

Author keywords

Atopic dermatitis; Birch pollen; Specific immunotherapy

Indexed keywords

POLLEN EXTRACT;

ADULT; ALLERGIC RHINITIS; ARTICLE; ATOPIC DERMATITIS; BIRCH; DISEASE SEVERITY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG SAFETY; ECZEMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PRURITUS; URTICARIA; VERTIGO;

ADOLESCENT; ADULT; AGED; BETULA; COHORT STUDIES; DERMATITIS, ATOPIC; FEMALE; HUMANS; IMMUNOGLOBULIN E; IMMUNOTHERAPY; MALE; MIDDLE AGED; PILOT PROJECTS; PLANT EXTRACTS; POLLEN; POLYMERIZATION; RHINITIS, ALLERGIC, SEASONAL; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79551559575     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000320058     Document Type: Article

References (17)

1. Jung T, Stingl G: Atopic dermatitis: therapeutic concepts evolving from new pathophysiologic insights. J Allergy Clin Immunol 2008;122:1074-1081.
2. Bieber T, Novak N: Pathogenesis of atopic dermatitis: new developments. Curr Allergy Asthma Rep 2009;9:291-294.
3. Larche M, Akdis CA, Valenta R: Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol 2006;6:761-771. (Pubitemid 44453462)
4. Calderon MA, Alves B, Jacobson M, Hurwitz B, Sheikh A, Durham S: Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev 2007;1:CD001936.
5. Werfel T, Breuer K, Rueff F, Przybilla B, Worm M, Grewe M, et al: Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study. Allergy 2006;61:202-205. (Pubitemid 43381831)
6. Silny W, Czarnecka-Operacz M: Specific immunotherapy in the treatment of patients with atopic dermatitis-results of double blind placebo controlled study (in Polish). Pol Merkur Lekarski 2006;21:558-565. (Pubitemid 46129193)
7. Bussmann C, Bockenhoff A, Henke H, Werfel T, Novak N: Does allergen-specific immunotherapy represent a therapeutic option for patients with atopic dermatitis? J Allergy Clin Immunol 2006;118:1292-1298.
8. Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 1993;186:23-31.
9. Larche M, Akdis CA, Valenta R: Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol 2006;6:761-771. (Pubitemid 44453462)
10. Bussmann C, Maintz L, Hart J, Allam JP, Vrtala S, Chen KW, et al: Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study. Clin Exp Allergy 2007;37:1277-1285. (Pubitemid 47372291)
11. Frew AJ: Allergen immunotherapy. J Allergy Clin Immunol 2010;125(suppl 2):S306-S313.
12. Kwon YS, Oh SH, Wu WH, Bae BG, Lee HJ, Lee MG, et al: CC chemokines as potential immunologic markers correlated with clinical improvement of atopic dermatitis patients by immunotherapy. Exp Dermatol 2009;19:246-251.
13. Czarnecka-Operacz M, Silny W: Specific immunotherapy in atopic dermatitis - Four-year treatment in different age and airborne allergy type subgroups. Acta Dermatovenerol Croat 2006;14:230-240. (Pubitemid 46154746)
14. Samochocki Z, Owczarek W, Rujna P, Raczka A: Hypersensitivity to aeroallergens in adult patients with atopic dermatitis develops due to the different immunological mechanisms. Eur J Dermatol 2007;17:520-524. (Pubitemid 350207164)
15. Wichmann K, Uter W, Weiss J, Breuer K, Heratizadeh A, Mai U, et al: Isolation of alpha-toxin-producing Staphylococcus aureus from the skin of highly sensitized adult patients with severe atopic dermatitis. Br J Dermatol 2009;161:300-305.
16. Breuer K, Wulf A, Constien A, Tetau D, Kapp A, Werfel T: Birch pollen-related food as a provocation factor of allergic symptoms in children with atopic eczema/dermatitis syndrome. Allergy 2004;59:988-994. (Pubitemid 39141412)
17. Reekers R, Busche M, Wittmann M, Kapp A, Werfel T: Birch pollen-related foods trigger atopic dermatitis in patients with specific cutaneous T-cell responses to birch pollen antigens. J Allergy Clin Immunol 1999;104:466-472. (Pubitemid 29420449)